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IPTH values during hemodialysis: Role of ionized Ca, dialysis mem-
branes and 1PTJI assays. The evolution of serum iPTH concentration
during hemodialysis was studied in eight patients who were dialyzed
with cuprophane (Cu) and polyacrylonitrile membranes (PAN) during
two four-hour sessions. Ca concentration in the dialysate was 1.37
mM/liter. iPTH was measured with an intact hormone immunoradio-
metric assay (I), with two late (L1, L2) and one mid (M) carboxylter-
minal immunoassays at the beginning and end of hemodialysis, from the
arterial and venous sides of the extracorporeal unit. Results are means
SD. Serum Ca increased during dialysis with Cu (1.26 0.08 vs.
1.33 0.03 mmol/Iiter, P < 0.05), without any change in the concen-
tration of iPTH measured with L1, L2 or M, but with a 50% decrease in
PTH measured with 1(21.8 19.2 vs. 10.3 9.0 pmol/liter, P < 0.05).
Serum Ca increased similarly with PAN (1.25 0.10 vs. 1.34 0.04
mmol/liter, P < 0.01), but there was a greater than 50% decrease in
iPTH concentration measurements for all four assays (I: 17.2 17 vs.
7.6 8.3 pmol/liter, P < 0.05; L1: 92 75 vs. 36 32 pmol/liter, P <
0.05; L2: 312 289 vs. 126 128 pmol/liter, P < 0.01; M: 926 1074
vs. 373 422 pmol/liter, P < 0.05). iPTH clearance was minimal
through Cu and significantly higher through PAN with I (124 33
mi/iiin, P < 0.005), L1 (79 17 mI/mm, P < 0.0005), L2 (83 19
mi/mm, P < 0.0005) and M (52 25 mI/mm, P < 0.05); since intact
hormone was cleared more readily than large fragments and the latter
more readily than small fragments, hydrophobic adherence to the PAN
was first postulated anu then demonstrated during in vitro dialysis of
'311-bPTH(1-84) and 1231-bPTH(41-84). Thus, increasing serum Ca
concentration during hemodialysis reduced the circulating level of
intact PTH by half without influencing the concentration of carboxyl-
terminal fragments. The concentration of the latter could be reduced by
more than 50%, and that of intact hormone by a further 25% by
selection of a PAN which permitted extracorporeal clearance of iPTH.
These results suggest that the predialysis concentration of iP'FH, and
mostly of intact iPTH, is best to evaluate the parathyroid status of
bemodialyzed patients, since various factors will influence iPTH con-
centration during and immediately after hemodialysis.
Once it had been demonstrated that i.v. calcium infusion
could decrease serum immunoreactive parathyroid hormone
(iPTH) in patients with chronic renal failure [1, 2], various
attempts were made to reduce secondaiy hyperparathyroidism
in these patients by increasing the calcium concentrationof the
dialysate during hemodialysis [3—8]. Although it was sometimes
possible to significantly reduce serum iPTH during hemodialy-
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sis by this means [2, 5, 8], no long-term effect could be
demonstratec on the parathyroid function [3, 4, 6, 7]. Initially,
dialysis membrane permeability to iPTH or its fragments was
not evaluated to explain the decrease in serum iPTH during
hemodialysis [2, 5, 8]. Later studies were able to demonstrate
some permeability of dialysis membranes to iPTH fragments
[9—14] and occasionally to intact PTH(1-84) [12]. If the decrease
in fragments could readily be explained by membrane perme-
ability and clearance, most authors felt that the decrease in
intact hormone was related to the increased serum concentra-
tion of calcium in these patients [12, 13]. Since dialysis mem-
branes of much greater permeability are now currently available
for hemodialysis, we were interested in seeing whether we
could significantly reduce all molecular forms of serum iPTH in
chronic renal failure during hemodialysis, irrespective of
changes in serum calcium. This study thus compares the
influence of two dialysis membranes of different permeability
on serum iPTH concentration during hemodialysis.
Methods
Subjects
Eight subjects suffering from chronic renal failure were
recruited from patients regularly attending our unit for hemo-
dialysis. They were aged from 20 to 69 and had been on
hemodialysis from 1 to 57 months. Glomerulonephritis was the
diagnosis in four patients, nephrosclerosis in two, focal sclero-
sis in one and chronic pyelonephritis in the other. All were
treated with aluminum hydroxide but none had had prior
parathyroid surgery nor a renal transplant. Informed consent
was obtained from the eight subjects.
Experimental protocol
In vivo dialysis. For each patient, iPTH diffusion across the
dialysis membrane was studied at the beginning and end of two
consecutive dialysis sessions. Half of the patients were first
dialyzed with a cuprophane membrane (Discap 160, Hospal),
and the other half with a polyacrylonitnie membrane (Filtral,
Hospal); the procedure was reversed for the second session.
These two hollow fiber membranes have similar surfaces areas
(Discap 160, 1.22 m2; Filtral, 1.15 m2) and urea clearance, but
the polyacrylonitrile has a greater permeability to middle mol-
ecules. Blood was sampled at the beginning and end of each
dialysis session from both the arterial and the venous puncture
sites of the extracorporeal circuit. For purposes of the study,
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both dialysis sessions were standardized at four hours and an
acetate dialysate was used containing 1.37 mmollliter ionized
Ca delivered at 500 ml min by a single pass delivery
system (Monitral, Hospal). Blood flow varied from 200 to 250
ml min1, but was maintained at the same rate for the two
sessions for any given patient. The ultrafiltration rate was
adjusted according to patient needs, but was turned off five
minutes before blood sampling.
In vitro dialysis. In vitro dialysis of '311-bPTH(l-84) and of
'251-bPTH(41-84) was next performed. lodination of bPTH(l-
84) with Na'251 or Na'311 (Amersham Canada Ltd., Oakville,
Ontario, Canada), generation of 1251-bPTH(41-84) by incubating
1251-bPTH(1-84) with rat kidney membranes, and purification of
both iodinated preparations by gel chromatography on Bio-Gel
P-100 (Bio-Rad Laboratories, Richmond, California, USA)
were accomplished as previously described [15, 16]. 1251
bPTH(41-84), 42.6 x 106 cpm, and 1311-bVFH(l-84), 18.6 x 10
cpm, were added to 1250 ml of serum coming from the plasma-
pheresis of one patient; this solution was further diluted to five
liters with NaC1 0.9%. This solution was then pumped at a flow
of 75 mllmin alternatively into three Discap 160 and three Filtral
filters. In this later case, filtration pressure was adjusted at 50,
100, 200, and 275 mm of Hg for periods of 10, 5, 5, and 5
minutes, respectively. For the former cuprophane membrane,
the filtration pressure was adjusted at 200 mm of Hg for 15
minutes and then 275 for 10 minutes. The ultrafiltrate and the
solution coming out of the filter were continuously returned to
the original five liter solution. Samples of the solution coming in
and out of the filter, as well as from the ultrafiltrate, were
obtained simultaneously from each filter at each of the filtration
pressures. Total protein concentration was measured by a
standard automated method and radioactivity estimated in a
dual energy Y-counter (Gamma 8000, Beckman Instruments,
Fullerton, California, USA). Ultrafiltrate flow was estimated
indirectly from the difference observed in total protein concen-
tration between the entrance and the exit of the filter.
The amount of '311-bPTH(l-84) and of '251-bPTH(41-84)
which adhered to each type of filter was also evaluated. The
plastic container of each filter was sawn and samples of fibers
coming from each third of a filter were obtained, weighed, and
counted in a dual energy Y-counter. Results for each filter
represent a mean of nine samples, three in each third of a filter;
they are expressed in cpmlg of fibers. This procedure was
necessary because the amount of 'I or i251 radioactivity
decreased progressively from entrance to exit.
Laboratory methods
Serum ionized calcium was measured within one hour of
sampling by a calcium sensitive electrode (ICA- 1, Radiometer,
Copenhagen). BUN, creatinine, total proteins, albumin, and
total calcium were measured by standard colorimetric methods
adapted to multianalyzer analysis. Serum parathyroid hormone
was measured by means of four different PTH immunoassays.
In each case, all the samples to be measured were analyzed
within a single assay. The first assay was a commercial radio-
immunometric assay for intact human PTH(l-84) (Allegro In-
tact PTH, Nichols Institute, San Juan Capistrano, California,
USA); the intra-assay coefficient of variation on duplicate was
3.1%. The second assay was a late carboxylterminal assay
developed in our laboratory [15]; antiserum C-52 was presatu-
rated with synthetic hPTH(44-68) to eliminate the low-affinity
mid carboxylterminal component and used at 1/50,000 final
dilution with '251-[tyr52]hPTH(52-84) as tracer and synthetic
hPTH(39-84) as standard. Under these conditions, the assay
reacted mainly with large carboxylterminal fragments of the
hormone [17]. The intra-assay coefficient of variation was 3.3%.
The third assay was also a late carboxylterminal assay devel-
oped in our laboratory [17]; antiserum C-97 was used at 1/60,000
final dilution with '251-[tyr52]hPTH(52-84) as tracer and syn-
thetic hPTH(39-84) as standard. Under these conditions, the
assay reacted mainly with large carboxylterminal fragments,
but also with smaller fragments not recognized by antiserum
C-52 [17]. The intra-assay coefficient of variation was 7.4%. The
last assay was a mid carboxylterminal assay developed by L.E.
Mallette [18, 19]; antiserum G-5 was used at 1/10,000 final
dilution with '251-[tyr43]hPTH(43-68) as tracer and hPTH(39-68)
as standard. This assay reacted with the molecular forms of
iPTH recognized by the other two late carboxylterminal assays
and also with large and small mid carboxylterminal fragments.
The intra-assay coefficient of variation was 5.2%. Other condi-
tions for the last three assays are as previously described [17,
19]. Assays C-52 and C-97 were performed first, followed by
the intact hormone assay and, finally, G-5. Some samples
were unavailable for the last two assays, decreasing the final
number of patients for the clearance studies. To obviate for the
hemoconcentration effect observed with both filters during
hemodialysis, iPTH values were corrected to the total protein
concentration observed in each patient at the beginning of
hemodialysis.
Samples from a single patient were analyzed by gel chroma-
tography. They were obtained during the early stages of each
dialysis session from both sides of the extracorporeal dialysis
unit. In each case, 2 ml plasma was fractionated on a 1.2 x 100
cm column ot Bio-Gel P-100 (Bio-Rad Laboratories), equili-
brated and eluted with a 0.1 M ammonium acetate buffer, pH
4.6, containing 1% bovine serum albumin. The 1 ml fractions
obtained were lyophilized and reconstituted with the IPTH
assay buffer; appropriate dilutions were then assayed with the
three carboxylterminal antisera. In these studies, standard
hPTH(l-84) was used to analyze the gel chromatography profile
region corresponding to hPTH(1-84), while standard hPTH(39-
84) was utilized to analyze that corresponding to carboxylter-
minal fragments [20]. iPl'H recovery was better than 80% for
each of the four profiles and the three different assays.
Statistical analysis
Paired f-tests were used for comparison. Results are ex-
pressed as means SD.
Results
The influence of each filter and a dialysate ionized calcium
concentration of 1.37 mmol/liter on various biochemical param-
eters following four hours of hemodialysis is illustrated at Table
1. The decrease in BUN and creatinine obser ed over the
dialysis period was similar with both filters. Although the
increase in pH was slightly higher with the polyacrylonitrile
filter, the post-dialysis pH was similar in both groups mainly
because pH was initially slightly lower with the polyacryloni-
trile membrane prior to dialysis. The increase in total proteins
and albumin was also significantly higher with this latter mem-
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brane, partially explaining the more pronounced increase in
total blood calcium. Post-dialysis ionized serum calcium was
higher, but similar, with both membranes. Despite the increase
in ionized calcium, serum iPTH measured with both late
carboxylterminal assays and with the mid carboxylterminal
assay did not decrease during hemodialysis with the cu-
prophane membrane; only intact iPTH decreased by about
50%. While there was a similar increase in ionized calcium with
the polyacrylonitrile membrane, serum iPTH measurements
decreased by more than 50% in each of the four assays during
hemodialysis. Final intact iPTH levels were 25% lower (P <
0.05) with the polyacrylonitrile filter.
Some of these results are explained by the technical dialysis
data on the patients (Table 2). Urea and creatinine clearances
were similar with both ifiters, explaining the similar decreases
in BUN and creatinine. Ultrafiltration was adjusted at a slightly
higher rate with the polyacrylonitrile membrane, hence the
higher concentrations of albumin, total proteins and total cal-
cium observed in this group. There was minimal extracorporeal
iPTH clearance with the cuprophane membrane at the begin-
ning or end of hemodialysis using any of the iPTH assays (Table
3). Furthermore, only for the mid assay was there a significant
decrease in the value observed between the beginning and end
of hemodialysis. On the other hand, with the polyacrylonitrile
membrane, iPTH clearances measured by the four iPTH assays
were present at the beginning and end of hemodialysis. Values
obtained with the intact hormone assay were very near those
observed for extracorporeal creatinine clearance at the begin-
fling of hemodialysis (Fig. 1) and significantly less at the end of
hemodialysis; iPTH clearances measured by means of the intact
hormone assay were also significantly higher than clearances
measured using the other three assays, both at the beginning
Patient
QBI
liter!
Filter
Cu
UF
prophane
Clur Clcr
Polya
UF
crylonit
CIr
rile
Clcr
liter! ml! ml! liter! ml! rn/-
no. miii 4 hr mm miii 4 hr miii mm
1 0.23 1.1 171 126 2.6 158 138
2 0.25 3.6 158 130 4.0 169 135
3 0.25 4.2 172 157 4.5 152 133
4 0.24 2.4 151 122 4.0 151 131
5 0.20 2.8 106 98 3.3 154 125
6 0.22 2.0 165 132 2.9 146 119
7 0.25 0.8 164 136 1.0 143 116
8 0.20 3.0 128 109 2.8 117 106
Mean 0.23 2.50 152 126 3.1k 149 125
SD 0.02 1.16 23 18 1.1 15 11
ultrafiltrate; Clr, urea
and end of hemodialysis. iPTH clearances measured with the
late carboxylterminal assays were about 60% of the intact
hormone clearance both at the beginning and the end of
hemodialysis, and these values were higher than those observed
with the mid carboxylterminal assay. With this latter assay,
iPTH clearances were similar at the beginning and at the end of
hemodialysis.
This is shown graphically in Figure 1, with the ratio of iPTH
clearance/creatinine clearance being illustrated for both filters,
at the beginning and end of hemodialysis. With cuprophane, the
mean ratio remains low at the beginning (Intact, 0.25 0.46;
Late C-52, 0.08 0.19; Late C-97, 0.03 0.24; Mid, 0.19
Table 1. Biochemical data in patients before and after 4 hours of hemodialysis with two different membranes at a dialysate Ca
concentration of 1.37 mM!liter
Parameters
measured
Filter
Cuprophane Polyacrylonitrile
Before After A Before After A
BUN 25.1 5.7 10.4 3.6C —14.6 4.7 29.3 7.7" 13.4 42" —16.0 4.4
mmo!!liter
Creatinine 913 258 439 112C —474 194 1037 301" 518 157' —519 154
junol!liter
pH 7.33 0.05 7.46 0.04C 0.13 0.03 7.30 006d 7.46 0.04C 0.17 004d
Proteins 65.0 5.0 71.0 8.0 6.0 6.7 64.6 3.9 75.0 9.1" 10.4 75d
g!liter
Albumin 38.4 3.3 40.6 6.4 2.2 4.2 38.4 3.0 43.8 6.6 5.4 4.2"
g!liter
Ca, 2.01 0.25 2.44 032b 0.43 0.37 1.95 0.27" 2.69 0.13C 0.75 0.24e
mmol!literCa 1.26 0.08 1.33 0.03a 0.07 0.07 1.25 0.10 1.34 004b 09
mmo!/liter
PTH-IRMA 21.8 19.2 10.3 9•Ø —11.5 12.0 17.2 17.0 7.6 g3ad —9.6 10.8
pmol!liter
PTH-Late C-52 105 93 94 108 —11 39 92 75 36 32ad 55 47"
pmol!liter
PTH-Late C-97 354 375 343 386 —11 59 312 289 126 128ad —186 164"
pmol/liter
PTH-Mid G-5 901 1049 701 732 —188 330 926 1074 373 422 —625 737"
pmol!liter
Results are means SD of 8 patients.
Before vs. after a P < 0.05," P <0.01, C <0.001
Cuprophane vs. polyacrylonitnle d p < 0.05, e p < 0.01, fp < 0.001, 5N = 7
Table 2. Technical dialysis data in patients
Abbreviations are: QBI, blood flow; UF,
clearance, Clr, creatinine clearance.
a Cuprophane vs. polyacrylonitrile: P < 0.05
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Table 3. Influence of dialysis filter characteristics on iPTH clearance
when iPTH is measured with assays of different specificity at the
beginning and end of 4 hours of hemodialysis
PTH assay
Cuprophane Polyacrylonitrile
Beginning End Beginning End
mi/mm
1) PTH-IRMA
2) PTH-Late C-52
3) PTH-Late C-97
4) PTH-Mid G-5
32
10
5
24
60
23
35
29k
—20
10
9
8
37' 124 33b
27 79 17cg
22 83 19C5
35dk 52 25
9064 1856 7gk
53 3bfl
Cuprophane vs. polyacrylonitrile, a P < 0.05, b P <0.005, P <
0.0005
Beginning vs. end, (Ip < 0.05, e p < 0.005
1 vs. 2,3,4, tp <0.05, S <0.005, h P <0.0005
2 vs. 3, 4, P < 0.05
3 vs. 4, P < 0.005kN7
'N=S
0.26) and end (Intact, —0.20 0.38; Late C-52, 0.08 0.20;
Late C-97, 0.08 0.18; Mid, —0.09 0.30) of hemodialysis.
With polyacrylonitrile, values are significantly higher at the
beginning (Intact, 0.99 0.27, P < 0.005; Late C-52, 0.63
0.11, P <0.0005; Late C-97, 0.66 0.13, P <0.0005; Mid, 0.42
0.21, P <0.05) and end (Intact, 0.72 0.12, P <0.0005; Late
C-52, 0.51 0.12, P < 0.0005; Late C-97, 0.46 0.08, P <
0.0005; Mid, 0.41 0.25, P < 0.05) of hemodialysis. Differ-
ences between the beginning and end of hemodialysis, in the
various iPTH assays are similar to those described for the iPTH
clearances.
Furthermore, when the gel chromatography profile of the
plasma iPTH entering and exiting each filter was analyzed with
the three carboxylterminal antisera at the beginning of hemodi-
alysis (Fig. 2), it could be seen that there was no quantitative
alteration in the various iPTH peaks with the cuprophane
membrane, when antisera C-52 and C-97 were used to measured
iPTH, and only a small difference in the smaller molecular
forms when antiserum G-5 was used. On the other hand, all
molecular forms of iPTH measured with the three different
antisera were less when passing through the polyacrylonitrile
membrane, explaining the clearance data.
Data obtained during in vitro dialysis of '311-bPTH( 1-84) and
'251-bPTH(4l-84) are shown in Table 4. The clearance of
'311-bPTH(1-84) was about 10 to 20 times higher with the
polyacrylonitrile membrane than with the cuprophane mem-
brane. '311-cpm recovered in the ultrafiltrate explained less than
5% of the clearance with the polyacrylonitrile membrane and
less than 15% with the other membrane. The clearance of
'251-bPTH(4l-84) was also 10 to 20 times higher with the
polyacrylonitrile membrane. '251-cpm in the ultrafiltrate ex-
plained at the maximum 25% of the clearance phenomenon with
this membrane, but most of the clearance with the cuprophane
membrane, although a large variation was observed in relation
with the very low clearance values. The amount of radioactivity
present on 1 g of fibers coming from the two different filters was
76451 2059 cpm of '25lodine and 51656 5599 of '31lodine for
the polyacrylonitrile filter (N = 2), and only 9517 2750 cpm of
'25lodine and 7580 849 cpm of '31lodine for the cuprophane
filter (N = 2). The ratio of 131J/125J was 0.40 0.03 in the serum
used for in vitro dialysis, and 0.68 0.05 and 0.82 0.15 in the
fibers coming from the polyacrylonitrile filter and the cu-
prophane filter, respectively, which is in accordance with the
greater adherence of'3 'I-bPTH(l -84) suggested by the preceed-
ing data.
Discussion
This study was designed to outline factors that could affect
plasma iPTH concentration during hemodialysis. Existing liter-
ature suggested that both dialysate Ca +concentration [3, 5, 8,
121 dialysis membrane [141 and also the type of PTH immu-
noassay used [3, 5, 8, 12] could influence the measurement of
plasma iPTH during hemodialysis. To control variables related
to these factors, we used a dialysate Ca + concentration of 1.37
mmol/liter which usually increases plasma Ca concentration
by 0.06 mmol/liter during four hours of dialysis and four
different PTH immunoassays, which together were able to
recognize most of the molecular forms of iPTU so far described
in circulation, including intact hormone or hPTH(1-84), large
late carboxylterminal fragments [17, 20], smaller late carboxyl-
terminal fragments [17] as well as large and small mid carbox-
ylterminal fragments [19]. We also selected a classical cu-
prophane membrane and a polyacrylonitrile membrane, more
permeable to middle molecules, for comparison purposes.
Both membranes were equally effective in reducing BUN and
creatinine and the extracorporeal clearance of these substances
was similar. Even though hemoconcentration was more marked
with the polyacrylonitrile filter, the level of ionized Ca
achieved at the end of hemodialysis was similar with both
filters. During dialysis with a cuprophane membrane, the in-
crease in ionized Ca only influenced the concentration of
intact iPTH, which decreased by 50%. Since the clearance of
intact hormone or of various fragments measured by the dif-
ferent assays through the cuprophane filter was minimal, we
conclude that a decreased secretion of intact hormone by the
parathyroid glands as well as a persistent endogenous hepatic
clearance of intact hormone in face of renal failure [21, 22]
contributed to the lower iPTH concentration. The fact that the
amount of hormone measured by various carboxylterminal
assays was not affected by hypercalcemia despite a decreased
production of intact hormone reflects the longer half-life of
these fragments in renal failure, the major role played by the
kidney in their metabolic clearance, and the lower capacity of
other tissues to clear these fragments [16]. The only exception
in some of our patients was a small extracorporeal clearance of
mid carboxylterminal iPTH in particular in the patient in whom
the gel chromatography profile of iPTH entering and exiting the
filter was performed at the beginning of hemodialysis.
Although some other studies [11, 13] have clearly demon-
strated permeability of the cuprophane membrane to small
amino or carboxylterminal fragments, and a concomitant de-
crease in circulation during hemodialysis, the overall influence
on circulating iPTH has been regarded as negligible or related to
the increase in serum Ca concentration during hemodialysis
[3, 5, 8, 10]. This is particularly true when concentrations of
Ca higher than 1.75 mmol/liter were used in the dialysate
with a predominantly aminoterminal antiserum [3, 8]. Lower
concentrations of Ca + in the dialysate and carboxylterminal
directed antisera resulted in virtually unchanged iPTH levels
[3—7, 14].
Very different results were obtained with the polyacryloni-
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FIg. 1. The ratio of iPTH clearance/creatinine
clearance is illustrated for the four iPTH assays
used, at the beginning (B, 0) and end (E, •) of
hemodialysis. Boxes represent mean SD.
Statistical significance: +, P < 0.05; x, P <
0.005; *, P < 0.0005.
true membrane. Despite a similar increase in ionized Ca
concentration, we observed more than 50% decrease in iPTH
concentrations measured with the four iPTH assays during
hemodialysis. Furthermore, we observed a significant iPTH
clearance through the ifiter with all the assays. Contrary to what
we had initially expected, clearance was more marked for intact
iPTH than for large fragments, and the same held true for large
versus smaller fragments. This indicates that physicochemical
properties of the membrane other than permeability to a given
molecular weight were involved in iPTH clearance. In fact, tL
clearances appeared directly related to the degree of hydropho-
bicity of the iPTH molecules as outlined during HPLC separa-
tion of the various molecular forms of iPTH found in circulation
[23]. This suggests that iPTH adhered to the filter. This hypoth-
esis was reinforced by the fact that the clearance of intact iPTH
or of late carboxylterminal fragments decreased at the end of
hemodialysis, while that of smaller mid carboxylterminal frag-
ments was less affected. This indicated that these fragments
may in part be cleared due to the greater permeability of the
polyacrylonitnle filter. Furthermore, even if the clearance of
intact iPTH was equal to the creatinine clearance with the
polyacrylonitnle membrane, the iPTH level measured at the
end of dialysis was only 25% lower than the level obtained with
the cuprophane membrane at a similar serum ionized calcium.
This indicated that extracorporeal clearance only explained part
of our results while decreased intact hormone secretion and
continuous endogenous hepatic clearance contributed to the
rest. Our results also demonstrated that extracorporeal clear-
ance, through selection of an appropriate filter, is an effective
way of acutely decreasing carboxylterminal fragments of iPTH
in renal failure.
Experiments with in vitro clearances of '311-bPTH(l-84) and
'251-bPTH(41-84) helped to determine precisely the role of
ultrafiltration and adhesion in the clearance of iPTH. In vitro
clearance of both tracers with the polyacrylonitrile membrane
was 10 to 12 times higher than with the cuprophane membrane,
in accord with the in vivo data. Furthermore, the amount of
radioactivity recovered in the ultrafiltrate only explained 5% of
1311-bPTH(l-84) and 20% of '251-bPTH(41-84) clearances, adhe-
sion explaining the remaining 95% and 80%, respectively. Even
0
Tube no.
Fig. 2. The gel chromatography profile of plasma iPTH entering (—)
and exiting (— — —) the extracorporeal dialysis unit is illustrated for the
same patient during two dialysis sessions, the first with a cuprophane
(Cu) membrane and the second with a polyacrylonitrile (PAN) mem-
brane. Samples were obtained at the beginning of dialysis. Analysis of
iPTH was performed with three different antisera. The position of
elution of the void volume (j) of intact '251-bPTH(l-84) () and '25lodine
(j) are indicated by arrows.
0
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Table 4. Influence of dialysis filter on '31I-bPTH(I-84) and
'251-bPTH(41-84) clearance in vitro
'25I-cpm
'311-bPTH '311-cpm in '251-bPTH in
Filtration (1-84) ultrafiltrate (41-84) ultrafiltrate
pressure clearance % of clearance % of
Filter mm Hg
50
mi/mm
35±14
clearance
1±1
mi/mm
32±15
clearance
2±2
Poly- 100 36 15 2 1 33 13 8 2
acrylonitrile 200 44 12 4 1 41 11 19 4
(N=3) 275 49±11
41 l31
5±2
3 2 49±1338 l3' 30±7IS 12
Cuprophane 200 2 2 14 13 2 2 87 63
(N=3) 275 4±0.1
3±1
19±19
16±13
2±2
2±2
73±57
81±53
Pump flow = mI/mm
polyacrylonitrile vs. cuprophane, a p < 0.005; b < 0.0005
if clearances were much smaller with the cuprophane mem-
brane, adhesion to the filter explained 85% of intact PTH
clearance but only 25% of big carboxylterminal fragment clear-
ance. In accord with this, 8 to 10 times more radioactivity was
recovered on fibers coming from the polyacrylonitrile filter and
the ratio of 131J/125j on these fibers also increased, reflecting the
greater clearance and adherence of 1311-bPTH(1-84) compared
to '251-bPTH(41-84). This was even more true of the cu-
prophane fibers, since in this last case most 'I-bPTH(1-84)
adhered to the filter while little of '251-bPTH(41-84) did the
same.
To our knowledge, this is the first detailed report demonstrat-
ing that the physicochemical properties of dialysis membranes
have a substantial effect on the concentration of circulating
molecular forms of PTH during hemodialysis. Fouchald, Gaut-
vik and Gautvik [12], however, studied PTH movements across
cellulose acetate, and demonstrated the presence of all the
circulating molecular forms of PTH in the ultrafiltrate, but they
only recorded a 10% decrease in circulating iPTH during four
hours of hemodialysis with an iPTH clearance of less than 12
mI/mm. Gueris et al [14] compared the influence of dialysis with
a cuprophane membrane and a polyacrylonitrile membrane on
serum carboxylterminal iPTH concentration and demonstrated
a 57% decrease with the latter membrane and none with the
former. They also explained their results via a greater perme-
ability of the polyacrylonitrile membrane, a hypothesis which is
refuted by our results. Furthermore, we have extended their
findings to all molecular forms of circulating iPTH.
The practical consequences of these findings can be analyzed
at various levels. First, iPTH measurements in hemodialyzed
patients will have to be performed taking into account variables
such as time since last dialysis, Ca concentration in the
dialysate, filter characteristics, and also the type of iPTH assay
selected. Since iPTH levels revert to predialysis levels, using
either filter [14] between two dialysis sessions, predialysis iPTH
concentration appears the most adequate single value to eval-
uate their parathyroid function. Also, the intact hormone assay
appears the most appropriate assay to study hormone secretion
under the influence of serum calcium concentration in these
patients, since other molecular forms of iPTH are little affected,
probably because of the very large peripheral pool in absence of
renal clearance [161. On the other hand, carboxylterminal
assays of iPTH could become useful tools to evaluate the
extracorporeal clearance of middle molecules by different fil-
ters, etc.
There is no doubt that plasma iPTH concentration reverts to
the previous level between two hemodialysis sessions in this
study as well as in a preceeding one using the same type of
filters [14). In the latter study, hemodialysis with a polyacry-
lonitrile membrane for three weeks also did not influence the
basal iPTH concentration and thus the secondary hyperpara-
thyroidism of these patients, as previously suggested by studies
covering Ca concentration in the dialysate [3—81. On the
other hand, hemodialyzed patients in general would be sub-
jected to less carboxylterminal iPTH and/or less middle mole-
cules [24) in between dialysis sessions, possibly reducing their
toxic effects [25, 26]. Although carboxylterminal fragments of
iPTH have previously been considered inert molecules, recent
data suggest that they may be mitogenic in vitro [27] and may
influence osteoblast-like cells in given circumstances [28]. The
relevance of these studies to renal failure is, for the moment,
purely speculative, but nonetheless our findings offer a possible
way of intervention.
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